Facebook Linkedin Twitter
Inside Precision Medicine Certain Diabetes Drugs May Lower Risk of Dementia and Parkinson’s Disease

Antidiabetic agents

Middle aged man with type 2 diabetes using blood sugar measurement device to monitor type 2 diabetes, which is often treated with SGLT2 inhibitors
News & Features

Certain Diabetes Drugs May Lower Risk of Dementia and Parkinson’s Disease

0
Digital Multimedia
Informatics

Dandelion Health Cracks Clinical Data Bottleneck Limiting AI in Healthcare

Jonathan D. Grinstein, PhD
0
Weight loss pills and unhealthy dieting with medication concept
News & Features

Study Identifies Key Factors for Long-Term Weight Loss with GLP-1 Medications

0
Obesity
News & Features

Obesity Drug Effective in Children

0
Older woman losing parts of head and looking confused as a symbol of dementia, which the type 2 diabetes treatment SGLT-2 inhibitors could help prevent
News & Features

SGLT-2 Inhibitors Could Help Prevent Dementia

0
Transparent blue image of human heart with monitored beat, which can be abnormal in people with long QT syndrome
News & Features

Lilly’s Tirzepatide Improves Heart Failure Outcomes

0
The glucagon like peptide-1 ( GLP-1) receptor , activated complex with an agonist (semaglutide) and G-proteins
Informatics

Tirzepatide Tops Semaglutide for Weight Loss in Type 2 Diabetes

0
Sleep Apnea Oxygen Mask Equipment
News & Features

Diabetes, Obesity Drug Shows Efficacy Treating Obstructive Sleep Apnea in Phase III Trials

0
Human pancreas, gall bladder organ model, 3d rendering.
News & Features

Fractyl Health’s GLP-1 Gene Therapy Outperforms Semaglutide in Mice

Jonathan D. Grinstein, PhD
0
Weight loss pills and unhealthy dieting with medication concept
News & Features

Precision Medicine for Obesity: Targeting a Multifactorial Condition

Helen Albert
0
1234Page 1 of 4

Related Content

Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.
Inside Precision Medicine